135 related articles for article (PubMed ID: 4787689)
1. [The dynamics of Vi-antibodies of different classes in typhoid patients during their treatment with levomycetin combined with alcoholic monovaccine and Vi-antigen].
Sukhoroslova LI; Deriagin IuP
Zh Mikrobiol Epidemiol Immunobiol; 1973 Oct; 50(10):15-8. PubMed ID: 4787689
[No Abstract] [Full Text] [Related]
2. [Clinico-immunological characteristics of the results of treatment of patients with typhoid by a complex method using VI-antigen, monovaccine, and levomycetin].
Bunin KV; Deriagin IuP
Sov Med; 1974 May; 37(5):8-12. PubMed ID: 4832529
[No Abstract] [Full Text] [Related]
3. [Immunologic shifts in typhoid patients following immuno-antibiotic therapy with levomycetin and VI-antigen according to the results of the passive VI-hemagglutination test].
Shneĭder VP
Zh Mikrobiol Epidemiol Immunobiol; 1966 Jun; 43(6):26-32. PubMed ID: 6004905
[No Abstract] [Full Text] [Related]
4. [Combined treatment of patients with typhoid with levomycetin, apilar, typhoid monovaccine and total ultraviolet irradiation].
Normanskiĭ ES; Ivanovskaia KN; Koshkin AI; Podlevskiĭ AF
Antibiotiki; 1966 May; 11(5):471-5. PubMed ID: 5993094
[No Abstract] [Full Text] [Related]
5. [Prevention of development of the bacterial carrier state through vaccine-antibiotic therapy of patients with typhoid and paratyphoid. 1. Pecularities of the course of thyphoid and paratyphoid in the complex therapy of patients with levomycetin and dry alcoholic typhoid-paratyphoid B divaccine].
Bilibin AF; Musabaev IK; Medvedev AS
Zh Mikrobiol Epidemiol Immunobiol; 1966 Mar; 43(3):107-12. PubMed ID: 4965909
[No Abstract] [Full Text] [Related]
6. [Experience with the treatment of typhoid fever with levomycetin and typhoid monovaccine].
STARSHINOVA VS
Sov Med; 1961 Dec; 25():64-9. PubMed ID: 13916379
[No Abstract] [Full Text] [Related]
7. [Prevention of bacterial carrier state in typhoid and paratyphoid patients by means of antibiotic-vaccineotherapy. II. The dynamics of immunologic indices in typhoid and paratyphoid patients treated with levomycetin and dry alcoholic typho-paratyphoid B divaccine].
Tendetnik IuIa; Kilesso VA; Vydrina EI; Leĭtman MZ; Taratorina OM
Zh Mikrobiol Epidemiol Immunobiol; 1966 Apr; 43(4):73-80. PubMed ID: 4978572
[No Abstract] [Full Text] [Related]
8. [Immunologic basis for typhoid carrier state formation and methods of prevention].
Bunin KV
Zh Mikrobiol Epidemiol Immunobiol; 1970 Sep; 47(9):5-10. PubMed ID: 5519106
[No Abstract] [Full Text] [Related]
9. [Treatment of typhoid with levomycetin combined with vaccination (intradermal and by electrophoresis)].
Alisov PA; Kazantsev AP
Sov Med; 1965 Sep; 28(9):66-71. PubMed ID: 5871702
[No Abstract] [Full Text] [Related]
10. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
[TBL] [Abstract][Full Text] [Related]
11. [Description of the Widal reaction in typhoid fever and paratyphoid treated with synthomycin and levomycetin].
MIKHAILOVA IuM
Antibiotiki (Mosc); 1957; 2(1):58-9. PubMed ID: 24544347
[No Abstract] [Full Text] [Related]
12. [The dynamics of 0-antibodies of various physico-chemical properties in typhoid fever treated with levomycetin and VI-antigen].
Sukhoroslova LI
Zh Mikrobiol Epidemiol Immunobiol; 1968; 45(10):111-4. PubMed ID: 5731554
[No Abstract] [Full Text] [Related]
13. [The content of Vi-antibodies and 7S Vi-antibodies in the serum of typhoid patients treated with Vi-antigen and levomycetin].
Sukhoroslova LI; Andreeva NP
Zh Mikrobiol Epidemiol Immunobiol; 1968 May; 45(5):83-7. PubMed ID: 5733721
[No Abstract] [Full Text] [Related]
14. [Clinical-epidemiological parallels in patients suffering from typhoid and paratyphoid fever treated with levomycetin in combination with vaccine].
Musabaev IK; Nevskiĭ MV; Ambartsumov SM; Mikhaĭlovskaia OG; Kotiuminskaia NA; David'ian AO
Sov Med; 1966 Jun; 29(6):64-9. PubMed ID: 4965445
[No Abstract] [Full Text] [Related]
15. Vaccines for preventing typhoid fever.
Anwar E; Goldberg E; Fraser A; Acosta CJ; Paul M; Leibovici L
Cochrane Database Syst Rev; 2014 Jan; (1):CD001261. PubMed ID: 24385413
[TBL] [Abstract][Full Text] [Related]
16. [Clinico-immunologic results of complex use of immunogenic preparations in the therapy of typhoid].
Bunin KV; Deriagin IuP
Zh Mikrobiol Epidemiol Immunobiol; 1974 Jan; (1):131. PubMed ID: 4454809
[No Abstract] [Full Text] [Related]
17. [The dynamics of 19S- and 7S-antibody formation in humans with regard to the dose and number of injections of paratyphoid B vaccine].
Kheĭfets LB; Levina LA; Drozd AK
Zh Mikrobiol Epidemiol Immunobiol; 1969 Jul; 46(7):33-8. PubMed ID: 4986748
[No Abstract] [Full Text] [Related]
18. [Current state of therapy of abdominal typhus].
Postovit VA
Sov Med; 1983; (8):54-8. PubMed ID: 6648654
[No Abstract] [Full Text] [Related]
19. [DYNAMICS OF THE H- AND O-AGGLUTININ TITERS IN TYPHOID PATIENTS TREATED WITH LEVOMYCETIN AND THE ANTIBIOTIC COMBINED WITH VACCINE].
ALISOV PA; KAZANTSEV AP
Zh Mikrobiol Epidemiol Immunobiol; 1964 Aug; 41():36-41. PubMed ID: 14255896
[No Abstract] [Full Text] [Related]
20. [Immunological indices in the digestive tract secretions in subcutaneous and oral vaccination against typhoid fever].
Pershin BB; Chakhava OV; Lebedev KA; Stefani DV; Torichneva LIu
Zh Mikrobiol Epidemiol Immunobiol; 1976 Nov; (11):124-30. PubMed ID: 1007722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
